Patent · US Active

Prevention and treatment of sarcopenia

US8835485B2 · kind B2 · utility

1Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 29, 2010
Grant dateSep 16, 2014
Priority date
Expiry dateApr 29, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/133
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a means for prevention and treatment of sarcopenia by administration of a substance that both reduces the sensibility of beta-adrenergic receptors and of 5-HT1a receptors. (S)-pindolol, (S)-propanol, tertalol, or bopindolol are preferred for this purpose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.